Table 1.
Summary of baseline characteristics of patients receiving repeat radioembolization.
| Characteristic | Repeat TreatmentNN = 26 | Single treatment onlyNN = 158 |
|---|---|---|
| Sex, M/F | 25 (96%)/1 (4%) | 142 (90%)/ 16 (10%) |
| Age | 65 yo (18–83.0) | 65 yo (14–88.0) |
| BCLC | ||
| A | 59.3% (n = 15/26) | 68.3% (n = 108/158) |
| B | 25.9% (n = 7/26) | 26.1% (n = 41/158) |
| C | 14.8% (n = 4/26) | 5.5% (n = 9/158) |
| CPS | ||
| A | 85.2% (n = 22/26) | 75.5% (n = 119/158) |
| B | 14.8% (4/26) | 24.5% (39/158) |
| MELD | 8.5 (SD: 2.36, Range: 6 to 14) | 9.8 (SD: 3.77, Range: 6 to 26) |
| Primary tumor Hepatocellular carcinoma Cholangiocarcinoma | 96.2% (n = 25/26) 3.8% (n = 1/26) | 94.3% (n = 149/158) 5.7% (n = 8/158) |
| Extra Hepatic Disease | 19.2% (n = 5/26) | 13.9% (n = 22/158) |
| Splenic Vein Thrombosis | ||
| Average time interval between first and second radioembolization | 9.6 months (1.0–52.0) | NA |